Cash Flow Artemis Medicare Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
107.00
68.00
50.00
37.00
7.00
30.00
Adjustment
48.00
60.00
49.00
38.00
30.00
33.00
Changes In working Capital
3.00
-4.00
30.00
-32.00
-8.00
-4.00
Cash Flow after changes in Working Capital
159.00
124.00
130.00
42.00
29.00
60.00
Cash Flow from Operating Activities
145.00
108.00
127.00
59.00
27.00
56.00
Cash Flow from Investing Activities
-385.00
-88.00
-158.00
-107.00
-37.00
-26.00
Cash Flow from Financing Activities
266.00
-28.00
38.00
44.00
17.00
-27.00
Net Cash Inflow / Outflow
26.00
-8.00
7.00
-3.00
7.00
2.00
Opening Cash & Cash Equivalents
14.00
22.00
15.00
19.00
11.00
9.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
41.00
14.00
22.00
15.00
19.00
11.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Artemis Medicare
Figures in Cr
standaloned Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
109.25
216.32
-107.00
-49.50%
Adjustment
44.25
25.22
19.00
75.46%
Changes In working Capital
-0.41
-23.8
23.00
98.28%
Cash Flow after changes in Working Capital
153.09
217.74
-64.00
-29.69%
Cash Flow from Operating Activities
139.08
156.75
-17.00
-11.27%
Cash Flow from Investing Activities
-388.28
-110.99
-278.00
-249.83%
Cash Flow from Financing Activities
276.96
-45.88
321.00
703.66%
Net Cash Inflow / Outflow
27.76
-0.12
27.00
23233.33%
Opening Cash & Cash Equivalents
13.26
61.6
-48.00
-78.47%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
41.01
61.48
-20.00
-33.30%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 33.78% vs -14.40% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
145.62
108.85
33.78%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
